Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

<p>Abstract</p> <p>Background</p> <p>Pulmonary hypertension (PH) is a life-threatening disease with poor prognosis. Encouraging efforts have been made to target the main vasoproliferative aspects of the disease. Promising emerging therapeutics are tyrosine kinase inhibi...

Full description

Bibliographic Details
Main Authors: Honecker Friedemann, Baumann Hans, Keller Gunhild, Hennigs Jan K, Kluge Stefan, Bokemeyer Carsten, Brümmendorf Tim H, Klose Hans
Format: Article
Language:English
Published: BMC 2011-05-01
Series:BMC Pulmonary Medicine
Subjects:
Pulmonary hypertension
drug induced
antiproliferative therapy
leukaemia
side effects
Online Access:http://www.biomedcentral.com/1471-2466/11/30

Internet

http://www.biomedcentral.com/1471-2466/11/30

Similar Items